Search Results 211-220 of 1013 for 2024vadodara
Title: A Phase 2 Randomized Open-label Study of MEDI-551 in Adults with Relapsed or Refractory DLBCL · Title: A Phase 1 Pharmacokinetic-pharmacodynamic Study Of ...
As a consulting statistician, Mr. Vierkant collaborates with a number of investigators in the Mayo Clinic Comprehensive Cancer Center, with much of his effort ...
Intensity-modulated radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors. Giving pembrolizumab with cisplatin and intensity-modulated ...
Vemurafenib and cobimetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as ...
The puporse of this trial is to compare less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients ...
The purpose of this study is to examine the utility of 68GaFAPI-46 PET/CT imaging in adult patients with biopsy-proven Pancreatic Ductal Adenocarcinoma (PDA) ...
Make your tax-deductible gift and be part of the cutting-edge research and care that's changing medicine. Donate.
My research focus includes center-specific outcomes, Donor Acute Kidney Injury, outcomes of Simultaneous Pancreas and Kidney transplants, and post-transplant ...
The purpose of this study is to assess treatment-related, patient-reported early QOL changes after stereotactic ablative body radiotherapy (SABR) using the EPIC ...
Dr. Kakar 00:31. Welcome everyone to Mayo Clinic Q&A. I'm Dr. Sanjay Kakar. Over the past year, health care workers have gone to many measures to protect ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.